Home › Coronary Artery Disease › NCT07559903
ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
RecruitingObservational study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * All adult patients (≥ 18 years of age) undergoing PCI for de novo CAD using DCB Exclusion Criteria: * Patients under the age of 18; PCI procedures without the utilization of DCB; PCI procedures for non de novo lesions
About the study
The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.
Sponsor: Emory University · Participants: 5,000 · Started: 2026-06
Contact the study team
- Daniel Gold, MD · Phone: 314-761-3396
Official record on ClinicalTrials.gov — NCT07559903
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.